134 related articles for article (PubMed ID: 22810087)
1. Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences.
Kwast AB; Groothuis-Oudshoorn KC; Grandjean I; Ho VK; Voogd AC; Menke-Pluymers MB; van der Sangen MJ; Tjan-Heijnen VC; Kiemeney LA; Siesling S
Breast Cancer Res Treat; 2012 Aug; 135(1):271-80. PubMed ID: 22810087
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
[TBL] [Abstract][Full Text] [Related]
3. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
4. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
Korhonen T; Kuukasjärvi T; Huhtala H; Alarmo EL; Holli K; Kallioniemi A; Pylkkänen L
Breast; 2013 Dec; 22(6):1119-24. PubMed ID: 23863867
[TBL] [Abstract][Full Text] [Related]
5. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.
Brouckaert O; Laenen A; Smeets A; Christiaens MR; Vergote I; Wildiers H; Moerman P; Floris G; Neven P;
Breast; 2014 Aug; 23(4):371-7. PubMed ID: 24530094
[TBL] [Abstract][Full Text] [Related]
7. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
9. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
[TBL] [Abstract][Full Text] [Related]
11. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast.
Fernández B; Paish EC; Green AR; Lee AH; Macmillan RD; Ellis IO; Rakha EA
J Clin Pathol; 2011 Nov; 64(11):995-1000. PubMed ID: 21712309
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
[TBL] [Abstract][Full Text] [Related]
14. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
Paumier A; Sagan C; Campion L; Fiche M; Andrieux N; Dravet F; Pioud R; Classe JM
J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):529-34. PubMed ID: 14593298
[TBL] [Abstract][Full Text] [Related]
15. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
16. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
19. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
20. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
